Close

Rating History for Mirati Therapeutics (MRTX) by Leerink Partners

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/7/2023 Andrew Berens Downgrade Market Perform
(Outperform)
58.00
(78.00)
56.27
(58.70)
4.32% Details